• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于克服癌症治疗中铂耐药性的铂(II)配合物-核定位序列肽杂交体

Platinum (II) complex-nuclear localization sequence peptide hybrid for overcoming platinum resistance in cancer therapy.

作者信息

Wlodarczyk Marek T, Dragulska Sylwia A, Camacho-Vanegas Olga, Dottino Peter R, Jarzęcki Andrzej A, Martignetti John A, Mieszawska Aneta J

机构信息

Department of Chemistry, Brooklyn College, The City University of New York, 2900 Bedford Avenue, Brooklyn NY 11210.

Ph.D. Program in Chemistry, The Graduate Center of the City University of New York, New York, NY 10016.

出版信息

ACS Biomater Sci Eng. 2018 Feb 12;4(2):463-467. doi: 10.1021/acsbiomaterials.7b00921. Epub 2018 Jan 9.

DOI:10.1021/acsbiomaterials.7b00921
PMID:32042890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7009786/
Abstract

Platinum therapy represents first line of treatment in many malignancies but its high systemic toxicity limits the therapeutic dosage. Herein, we report the synthesis of carboplatin-like complexes with azide and alkyne functional groups and the formation of a platinum (II) - nuclear localization sequence peptide (Pt-NLS) hybrid to improve the import of platinum (II) complexes directly into the cell's nucleus. The Pt-NLS hybrid successfully enters cells and their nuclei, forming Pt-induced nuclear lesions. The in vitro efficacy of Pt-NLS is high, superior to native carboplatin at the same concentration. The methodology used is simple and cost-effective and most importantly can easily be extended to load the Pt (II) onto other supports, opening new possibilities for enhanced delivery of Pt (II) therapy.

摘要

铂类疗法是许多恶性肿瘤的一线治疗方法,但其高全身毒性限制了治疗剂量。在此,我们报告了具有叠氮化物和炔烃官能团的卡铂类配合物的合成,以及铂(II)-核定位序列肽(Pt-NLS)杂化物的形成,以改善铂(II)配合物直接导入细胞核的过程。Pt-NLS杂化物成功进入细胞及其细胞核,形成铂诱导的核损伤。Pt-NLS的体外疗效很高,在相同浓度下优于天然卡铂。所使用的方法简单且具有成本效益,最重要的是可以很容易地扩展到将铂(II)负载到其他载体上,为增强铂(II)治疗的递送开辟了新的可能性。

相似文献

1
Platinum (II) complex-nuclear localization sequence peptide hybrid for overcoming platinum resistance in cancer therapy.用于克服癌症治疗中铂耐药性的铂(II)配合物-核定位序列肽杂交体
ACS Biomater Sci Eng. 2018 Feb 12;4(2):463-467. doi: 10.1021/acsbiomaterials.7b00921. Epub 2018 Jan 9.
2
Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues.核定位信号靶向聚乙二醇共轭物作为卡铂类似物的潜在载体和核定位剂
Bioconjug Chem. 2004 Jul-Aug;15(4):814-23. doi: 10.1021/bc0499331.
3
The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand (review).含1,2 - 二氨基环己烷载体配体的铂配合物的化学与生物学(综述)
Int J Oncol. 1995 Jun;6(6):1291-305. doi: 10.3892/ijo.6.6.1291.
4
An alkyne-appended, click-ready Pt(II) complex with an unusual arrangement in the solid state.炔基附加的点击准备 Pt(II) 配合物在固态中具有不寻常的排列。
Angew Chem Int Ed Engl. 2015 Jan 12;54(3):1032-5. doi: 10.1002/anie.201409853. Epub 2014 Nov 27.
5
Multifunctional Pt(II) Reagents: Covalent Modifications of Pt Complexes Enable Diverse Structural Variation and In-Cell Detection.多功能 Pt(II) 试剂:Pt 配合物的共价修饰使结构具有多样性变化并能在细胞内进行检测。
Acc Chem Res. 2016 Jan 19;49(1):56-66. doi: 10.1021/acs.accounts.5b00322. Epub 2015 Dec 7.
6
Efficient Subcellular Targeting to the Cell Nucleus of Quantum Dots Densely Decorated with a Nuclear Localization Sequence Peptide.高效亚细胞靶向至密集修饰有核定位序列肽的量子点的细胞核。
ACS Appl Mater Interfaces. 2016 Jan 27;8(3):2001-9. doi: 10.1021/acsami.5b10295. Epub 2016 Jan 14.
7
Azide vs Alkyne Functionalization in Pt(II) Complexes for Post-treatment Click Modification: Solid-State Structure, Fluorescent Labeling, and Cellular Fate.叠氮化物与炔烃在 Pt(II) 配合物中的功能化用于后处理点击修饰:固态结构、荧光标记和细胞命运。
J Am Chem Soc. 2015 Dec 9;137(48):15169-75. doi: 10.1021/jacs.5b09108. Epub 2015 Nov 24.
8
Development of a novel carboplatin like cytoplasmic trackable near infrared fluorophore conjugate via strain-promoted azide alkyne cycloaddition.通过应变促进的叠氮化物-炔烃环加成反应开发新型类似卡铂的细胞质可追踪近红外荧光团缀合物。
J Inorg Biochem. 2018 May;182:150-157. doi: 10.1016/j.jinorgbio.2018.02.010. Epub 2018 Feb 21.
9
Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.基于咪唑菲咯啉的多吡啶配体的铂(II)配合物作为潜在的抗癌剂:合成、表征、体外细胞毒性研究以及与顺铂、卡铂和奥沙利铂的比较从头算和 DFT 研究。
J Biol Inorg Chem. 2018 Jul;23(5):833-848. doi: 10.1007/s00775-018-1579-z. Epub 2018 Jun 14.
10
Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.新型含 5-甲基-5-(2-巯基乙基)乙内酰脲的铂配合物的合成、光谱性质、晶体结构和生物评价。
Anticancer Agents Med Chem. 2019;19(10):1243-1252. doi: 10.2174/1871520619666190214103345.

引用本文的文献

1
Identification and validation of a novel risk model based on cuproptosis‑associated m6A for head and neck squamous cell carcinoma.基于铜死亡相关 m6A 的新型风险模型对头颈鳞状细胞癌的鉴定和验证。
BMC Med Genomics. 2024 May 22;17(1):137. doi: 10.1186/s12920-024-01916-5.
2
PLA2G4A and ACHE modulate lipid profiles via glycerophospholipid metabolism in platinum-resistant gastric cancer.PLA2G4A 和 ACHE 通过甘油磷脂代谢调节铂耐药胃癌中的脂质谱。
J Transl Med. 2024 Mar 7;22(1):249. doi: 10.1186/s12967-024-05055-4.
3
Unlocking the potential of platinum drugs: organelle-targeted small-molecule platinum complexes for improved anticancer performance.释放铂类药物的潜力:用于改善抗癌性能的细胞器靶向小分子铂配合物
RSC Chem Biol. 2023 Oct 3;4(12):1003-1013. doi: 10.1039/d3cb00087g. eCollection 2023 Nov 29.
4
H-Dot Mediated Nanotherapeutics Mitigate Systemic Toxicity of Platinum-Based Anticancer Drugs.H 点介导的纳米治疗减轻基于铂的抗癌药物的全身毒性。
Int J Mol Sci. 2023 Oct 23;24(20):15466. doi: 10.3390/ijms242015466.
5
Pt(II)-PLGA Hybrid in a pH-Responsive Nanoparticle System Targeting Ovarian Cancer.靶向卵巢癌的pH响应性纳米粒子系统中的铂(II)-聚乳酸-羟基乙酸共聚物杂化物
Pharmaceutics. 2023 Feb 10;15(2):607. doi: 10.3390/pharmaceutics15020607.
6
First-in-Class Dual Hybrid Carbonic Anhydrase Inhibitors and Transient Receptor Potential Vanilloid 1 Agonists Revert Oxaliplatin-Induced Neuropathy.首创的双重混合碳酸酐酶抑制剂和瞬时受体电位香草素 1 激动剂逆转奥沙利铂诱导的神经病变。
J Med Chem. 2023 Jan 26;66(2):1616-1633. doi: 10.1021/acs.jmedchem.2c01911. Epub 2023 Jan 10.
7
Recent advances in metallopolymer-based drug delivery systems.基于金属聚合物的药物递送系统的最新进展。
RSC Adv. 2019 Nov 13;9(63):37009-37051. doi: 10.1039/c9ra06678k. eCollection 2019 Nov 11.
8
A click-based modular approach to introduction of peroxides onto molecules and nanostructures.一种基于点击反应的将过氧化物引入分子和纳米结构的模块化方法。
RSC Adv. 2020 Dec 16;10(72):44408-44429. doi: 10.1039/d0ra09088c. eCollection 2020 Dec 9.
9
Investigating the role of peptides in effective therapies against cancer.研究肽在抗癌有效疗法中的作用。
Cancer Cell Int. 2022 Mar 27;22(1):139. doi: 10.1186/s12935-022-02553-7.
10
Platinum-based drugs for cancer therapy and anti-tumor strategies.铂类药物用于癌症治疗和抗肿瘤策略。
Theranostics. 2022 Feb 7;12(5):2115-2132. doi: 10.7150/thno.69424. eCollection 2022.

本文引用的文献

1
Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.抑制核输出受体 XPO1 作为铂类耐药性卵巢癌的治疗靶点。
Clin Cancer Res. 2017 Mar 15;23(6):1552-1563. doi: 10.1158/1078-0432.CCR-16-1333. Epub 2016 Sep 20.
2
The Platin-X series: activation, targeting, and delivery.铂-X 系列:激活、靶向与递送。
Dalton Trans. 2016 Aug 16;45(33):12992-3004. doi: 10.1039/c6dt01738j.
3
Platinum-based drugs: past, present and future.铂类药物:过去、现在与未来。
Cancer Chemother Pharmacol. 2016 Jun;77(6):1103-24. doi: 10.1007/s00280-016-2976-z. Epub 2016 Feb 17.
4
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.下一代铂类药物:靶向铂(II)剂、纳米颗粒递送及铂(IV)前药
Chem Rev. 2016 Mar 9;116(5):3436-86. doi: 10.1021/acs.chemrev.5b00597. Epub 2016 Feb 11.
5
Targeting Tumors with Small Molecule Peptides.用小分子肽靶向肿瘤
Curr Cancer Drug Targets. 2016;16(6):489-508. doi: 10.2174/1568009616666151130214646.
6
An integrin-targeted photoactivatable Pt(IV) complex as a selective anticancer pro-drug: synthesis and photoactivation studies.一种靶向整合素的光可激活铂(IV)配合物作为选择性抗癌前药:合成与光激活研究
Chem Commun (Camb). 2015 Jun 4;51(44):9169-72. doi: 10.1039/c5cc03180j.
7
Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.通过与含RGD肽偶联将铂(IV)前药靶向递送至癌细胞。
Dalton Trans. 2015 Jan 7;44(1):202-12. doi: 10.1039/c4dt02710h.
8
Cisplatin in cancer therapy: molecular mechanisms of action.顺铂在癌症治疗中的作用:分子作用机制
Eur J Pharmacol. 2014 Oct 5;740:364-78. doi: 10.1016/j.ejphar.2014.07.025. Epub 2014 Jul 21.
9
Targeting mitochondrial DNA with a platinum-based anticancer agent.用一种铂类抗癌剂靶向线粒体DNA。
Chem Biol. 2013 Nov 21;20(11):1323-8. doi: 10.1016/j.chembiol.2013.08.010. Epub 2013 Oct 31.
10
Evaluating cell lines as tumour models by comparison of genomic profiles.通过基因组图谱比较评估细胞系作为肿瘤模型。
Nat Commun. 2013;4:2126. doi: 10.1038/ncomms3126.